4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure

      research-article
      , MD, , MD, , MD
      The Canadian journal of cardiology

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Resistant or difficult to treat hypertension is defined as high blood pressure that remains uncontrolled with 3 or more different antihypertensive medications, including a diuretic. Recent definitions also include controlled blood pressure with use of 4 or more medications as also being resistant to treatment. Recently, refractory hypertension, an extreme phenotype of antihypertensive treatment failure has been defined as hypertension uncontrolled with use of 5 or more antihypertensive agents, including a long-acting thiazide diuretic and a mineralocorticoid receptor antagonist. Patients with resistant vs refractory hypertension share similar characteristics and comorbidities, including obesity, African American race, female sex, diabetes, coronary heart disease, chronic kidney disease, and obstructive sleep apnea. Patients with refractory vs resistant hypertension tend to be younger and are more likely to have been diagnosed with congestive heart failure. Refractory hypertension might also differ from resistant hypertension in terms of underlying cause. Preliminary evidence suggests that refractory hypertension is more likely to be neurogenic in etiology (ie, heightened sympathetic tone), vs a volume-dependent hypertension that is more characteristic of resistant hypertension in general.

          Related collections

          Author and article information

          Journal
          8510280
          2725
          Can J Cardiol
          Can J Cardiol
          The Canadian journal of cardiology
          0828-282X
          1916-7075
          30 September 2017
          08 July 2015
          May 2016
          11 October 2017
          : 32
          : 5
          : 603-606
          Affiliations
          Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Alabama, USA
          Author notes
          Corresponding author: Dr David A. Calhoun, 430 BMR2, 1530 3rd Ave S, Birmingham, Alabama 35242, USA. Tel.: +1-205-934-9281; fax: +1-205-934-1302. dcalhoun@ 123456uab.edu
          Article
          PMC5636623 PMC5636623 5636623 nihpa909253
          10.1016/j.cjca.2015.06.033
          5636623
          26514749
          12f0897f-8e7f-4927-9243-a3c2208c4703
          History
          Categories
          Article

          Comments

          Comment on this article